These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38991494)

  • 1. Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay.
    Hamiko M; Gerdes L; Silaschi M; Seidel H; Westhofen P; Kruppenbacher J; Hertfelder HJ; Oldenburg J; Bakhtiary F; Velten M; Oezkur M; Duerr GD
    Thromb Res; 2024 Sep; 241():109094. PubMed ID: 38991494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.
    Spangenberg T; Budde U; Schewel D; Frerker C; Thielsen T; Kuck KH; Schäfer U
    JACC Cardiovasc Interv; 2015 Apr; 8(5):692-700. PubMed ID: 25946442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement.
    Grodecki K; Zbroński K; Przybyszewska-Kazulak E; Olasińska-Wiśniewska A; Wilimski R; Rymuza B; Scisło P; Czub P; Koper D; Kochman J; Pawlak K; Ciepiela O; Grygier M; Jemielity M; Lesiak M; Filipiak KJ; Opolski G; Huczek Z
    J Thromb Thrombolysis; 2019 Nov; 48(4):610-618. PubMed ID: 31359325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
    Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
    Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases.
    Perrone MA; Viola FG; Minieri M; Caporali S; Copponi A; Sancesario G; Angeletti S; Massoud R; Romeo F; Bernardini S; Terrinoni A
    Folia Biol (Praha); 2020; 66(4):133-141. PubMed ID: 33745260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
    Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
    Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
    Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
    Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Aortic Valve Stenosis.
    Frank RD; Lanzmich R; Haager PK; Budde U
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.
    Gebhard C; Maafi F; Stähli BE; Bonnefoy A; Gebhard CE; Nachar W; de Oliveira Moraes AB; Mecteau M; Mihalache-Avram T; Lavoie V; Kernaleguen AE; Shi Y; Busseuil D; Chabot-Blanchet M; Perrault LP; Rhainds D; Rhéaume E; Tardif JC
    Thromb Haemost; 2018 Feb; 118(2):288-297. PubMed ID: 29443370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
    Casonato A; Galletta E; Cella G; Barbon G; Daidone V
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI.
    Roth N; Heidel C; Xu C; Hubauer U; Wallner S; Meindl C; Holzamer A; Hilker M; Creutzenberg M; Sossalla S; Maier L; Jungbauer C; Debl K
    Clin Res Cardiol; 2022 Dec; 111(12):1348-1357. PubMed ID: 35838799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
    Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
    J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automated von Willebrand factor multimer assay for von Willebrand disease: Further validation, benefits and limitations.
    Oliver S; Vanniasinkam T; Mohammed S; Vong R; Favaloro EJ
    Int J Lab Hematol; 2019 Dec; 41(6):762-771. PubMed ID: 31508897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
    Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
    Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.
    Varghese SS; Hetu MF; Bowman M; Herr J; Al-Turki M; Jaff Z; James P; Malik P; Payne D; Johri AM
    Haemophilia; 2023 Sep; 29(5):1306-1312. PubMed ID: 37428626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.